Isovurex

Ezetimibe, the active ingredient in Isovurex, is a cholesterol absorption inhibitor presented as an oral tablet for prescription use. It lowers elevated cholesterol levels and is indicated for patients with hypercholesterolemia, heterozygous familial hypercholesterolemia, and primary hyperlipidemia. The drug works by selectively blocking the NPC1L1 transporter in the intestinal wall, reducing the amount of dietary and biliary cholesterol that enters the bloodstream.

GNH USA supplies Isovurex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isovurex (ezetimibe) is used to manage disorders of lipid metabolism, particularly elevated cholesterol levels.

Hypercholesterolemia: reduces low‑density lipoprotein (LDL) cholesterol and total cholesterol concentrations. Heterozygous familial hypercholesterolemia: lowers LDL cholesterol in patients with genetically elevated cholesterol. Primary hyperlipidemia: improves overall lipid profile by decreasing cholesterol absorption.

Ezetimibe may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Abdominal pain: mild discomfort in the stomach area. - Diarrhea: loose or watery stools. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Myopathy: muscle weakness or pain that may indicate muscle injury. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Cholestatic hepatitis: liver inflammation with impaired bile flow.

When prescribing ezetimibe, clinicians should consider several safety measures to minimize risks.

Monitor liver function: check hepatic enzymes before initiating therapy and periodically during treatment. Assess lipid profile: evaluate cholesterol levels to determine therapeutic response. Review gallbladder disease history: ezetimibe may affect bile composition. Use caution in hepatic impairment: dose adjustment may be required. Avoid in patients with active liver disease: contraindicated due to potential liver toxicity. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Ezetimibe can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Bile acid sequestrants (e.g., cholestyramine): reduce ezetimibe absorption. - Cyclosporine: increases ezetimibe plasma concentrations, raising risk of adverse effects.

Moderate Interactions (Monitor Closely): - Statins (e.g., simvastatin, atorvastatin): combined use may increase risk of myopathy. - Fibrates (e.g., gemfibrozil): may enhance muscle toxicity when used together. - Warfarin: ezetimibe may affect INR, requiring closer monitoring.